Chimeric antigen receptor T-cell therapy — assessment and management of toxicities

Overview of attention for article published in Nature Reviews Clinical Oncology, September 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#9 of 2,575)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 35 news outlets
blogs: 2 blogs
policy: 2 policy sources
twitter: 266 X users
patent: 110 patents

facebook: 10 Facebook pages
wikipedia: 1 Wikipedia page
googleplus: 2 Google+ users
reddit: 1 Redditor
guideline: 11 clinical guideline sources

Readers on

mendeley: 1891 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 10 public wall posts from 10 users.

Precision Medicine World Conference - PMWCintl, 03 Oct 2017

Researchers develop guidelines for management of the potentially fatal side effects of CAR-T https://t.co/NFEUQwLzJY https://t.co…

Nature, 25 Sep 2017

Chimeric antigen receptor (CAR) T-cell therapies are showing great promise in the treatment of cancer, but are associated with…

Nature Biotechnology, 22 Sep 2017

Chimeric antigen receptor (CAR) T-cell therapies are showing great promise in the treatment of cancer, but are associated with…

Genética Médica Querétaro, 22 Sep 2017

Chimeric antigen receptor (CAR) T-cell therapies are showing great promise in the treatment of cancer, but are associated with…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity, including 6 additional Facebook posts.